TABLE 2.
Antimicrobial susceptibility of a reference strain and six clinical isolates of Acinetobacter genomic species 10
| Antimicrobial agent(s) | MIC (μg/ml) for indicated strain |
||||||
|---|---|---|---|---|---|---|---|
| 568 | 634 | 649 | 1091 | 1279 | 1312 | ATCC 17924 | |
| Amikacin | <2 | <2 | <2 | <2 | 16 | <2 | <2 |
| Gentamicin | <1 | <1 | <1 | <1 | >16 | <1 | <1 |
| Tobramycin | <1 | <1 | <1 | <1 | 8 | <1 | <1 |
| Ampicillin | >32 | >32 | 16 | >32 | >32 | >32 | 16 |
| Ampicillin-sulbactam | <2 | <2 | <2 | <2 | <2 | <2 | <2 |
| Piperacillin | 8 | 8 | 8 | 8 | 8 | 8 | <4 |
| Piperacillin-tazobactam | <4 | <4 | <4 | <4 | <4 | <4 | <4 |
| Cefazolin | >64 | >64 | >64 | >64 | >64 | >64 | >64 |
| Cefuroxime | 16 | 32 | 16 | 32 | 32 | 16 | 16 |
| Cefotetan | >64 | >64 | >64 | >64 | >64 | >64 | >64 |
| Ceftazidime | 8 | 16 | 4 | 16 | 16 | 8 | 4 |
| Ceftriaxone | 16 | 16 | 8 | 16 | 16 | 16 | 4 |
| Cefepime | 2 | 2 | <1 | 2 | 2 | 2 | 2 |
| Aztreonam | 32 | >64 | 16 | >64 | >64 | >64 | 16 |
| Imipenem | <1 | <1 | <1 | <1 | <1 | <1 | <1 |
| Meropenem | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Ciprofloxacin | <0.25 | >4 | 2 | <0.25 | >4 | <0.25 | <0.25 |
| Levofloxacin | <0.25 | 2 | 1 | <0.25 | 1 | <0.25 | <0.25 |
| TMP-SMXa | <20 | <20 | >320 | <20 | >320 | <20 | 160 |
| Colistin | 2 | 2 | 4 | 16 | 8 | 1 | 4 |
a
TMP-SMX, trimethoprim-sulfamethoxazole.